Oncotarget
The cover for issue 40 of Oncotarget features Figure 7, "Model figure of ETHE1 roles in FAP," by Witherspoon, et al.
Targeting proteostasis and autophagy in SMARCB1-deficient malignancies: where next? |
https://doi.org/10.18632/oncotarget.26970 Pavlos Msaouel, Alessandro Carugo, and Giannicola Genovese |
3979-3981 |
PDF | How to cite | Order a Reprint |
The non-random landscape of somatically-acquired uniparental disomy in cancer |
https://doi.org/10.18632/oncotarget.26987 Pau Erola, Keyvan Torabi, Rosa Miró, and Jordi Camps |
3982-3984 |
PDF | How to cite | Order a Reprint |
Cancer vaccines: what’s next? |
https://doi.org/10.18632/oncotarget.27006 Stéphane Depil, Paola Bonaventura, and Vincent Alcazer |
3985-3987 |
PDF | How to cite | Order a Reprint |
VEGF-C as a putative therapeutic target in cancer |
https://doi.org/10.18632/oncotarget.27007 Signe R. Michaelsen, Hans S. Poulsen, and Petra Hamerlik |
3988-3990 |
PDF | How to cite | Order a Reprint |
Diffuse large B-cell lymphoma: the stuff of cell-of-origin and microenvironment |
https://doi.org/10.18632/oncotarget.27013 Stefano A. Pileri, Maria Carmela Vegliante, and Sabino Ciavarella |
3991-3993 |
PDF | How to cite | Order a Reprint |
Advanced MRI in neuro-oncology: can we proceed without inclusion of energy metabolism? |
https://doi.org/10.18632/oncotarget.27015 Andreas Stadlbauer, Michael Buchfelder, Arnd Dörfler, and Stefan Oberndorfer |
3994-3995 |
PDF | How to cite | Order a Reprint |
Mesothelioma: Hippo pathway as a target, lessons from COMMAND |
https://doi.org/10.18632/oncotarget.27018 Dean A. Fennell, and Essa Y. Baitei |
3996-3997 |
PDF | How to cite | Order a Reprint |
From rare to well-done: importance of rare tumors in cancer therapeutic advances |
https://doi.org/10.18632/oncotarget.27020 Florence Duffaud, Sophie Piperno-Neumann, Nicolas Penel, and Jean-Yves Blay |
3998-3999 |
PDF | How to cite | Order a Reprint |
An emerging role of CD9 in stemness and chemoresistance |
https://doi.org/10.18632/oncotarget.27021 Mujib Ullah, Asma Akbar, and Avnesh S. Thakor |
4000-4001 |
PDF | How to cite | Order a Reprint |
Targeted therapy in CLL: changing the treatment paradigm |
https://doi.org/10.18632/oncotarget.26964 Christof Schneider, Daniela Steinbrecher, and Stephan Stilgenbauer |
4002-4003 |
PDF | How to cite | Order a Reprint |
ETHE1 overexpression promotes SIRT1 and PGC1α mediated aerobic glycolysis, oxidative phosphorylation, mitochondrial biogenesis and colorectal cancer |
https://doi.org/10.18632/oncotarget.26958 Mavee Witherspoon, Davinder Sandu, Changyuan Lu, Kehui Wang, Robert Edwards, Anthony Yeung, Ozkan Gelincik, Giovanni Manfredi, Steven Gross, Levy Kopelovich, and Steven Lipkin |
4004-4017 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.26998 Celina Ang, Samuel J. Klempner, Siraj M. Ali, Russell Madison, Jeffrey S. Ross, Eric A. Severson, David Fabrizio, Aaron Goodman, Razelle Kurzrock, James Suh, and Sherri Z. Millis |
4018-4025 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Somatic molecular analysis augments cytologic evaluation of pancreatic cyst fluids as a diagnostic tool |
https://doi.org/10.18632/oncotarget.26999 Ali Sakhdari, Parnian Ahmadi Moghaddam, Chi Young Ok, Otto Walter, Keith Tomaszewicz, Mandi-Lee Caporelli, Xiuling Meng, Jennifer LaFemina, Giles Whalen, Edward Belkin, Jaroslav Zivny, Wahid Wassef, Bruce A. Woda, Lloyd M. Hutchinson, and Ediz F. Cosar |
4026-4037 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology–morphological and therapeutic implications |
https://doi.org/10.18632/oncotarget.27005 Maria-Magdalena Georgescu, Yan Li, Mohammad Zahidul Islam, Christina Notarianni, Hai Sun, Adriana Olar, and Gregory N. Fuller |
4038-4052 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Impact of eIF4E phosphorylation at Ser209 via MNK2a on tumour recurrence after curative surgery in localized clear cell renal cell carcinoma |
https://doi.org/10.18632/oncotarget.27017 Osamu Ichiyanagi, Hiromi Ito, Sei Naito, Takanobu Kabasawa, Hidenori Kanno, Takafumi Narisawa, Masaki Ushijima, Yuta Kurota, Michinobu Ozawa, Toshihiko Sakurai, Hayato Nishida, Tomoyuki Kato, Mitsunori Yamakawa, and Norihiko Tsuchiya |
4053-4068 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.23861 Yongshun Chen, Xiaoyuan Wu, Daxuan Hao, Xinyu Cheng, Lei Zhang, Yougai Zhang, Shaobo Ke, Wei Shi, and Chunyu He |
4069-4078 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Correction: Glucocorticoid impairs cell-cell communication by autophagy-mediated degradation of connexin 43 in osteocytes |
https://doi.org/10.18632/oncotarget.27035 Junjie Gao, Tak Sum Cheng, An Qin, Nathan J. Pavlos, Tao Wang, Kai Song, Yan Wang, Lianzhi Chen, Lin Zhou, Qing Jiang, Hiroshi Takayanagi, Sheng Yan, and Minghao Zheng |
4079-4079 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC